Chronic Lymphocytic Leukemia (CLL) Monitoring, MRD Detection, Blood
Cancer Antigen (CA) 27- 29
Vanillylmandelic Acid (VMA) and Homovanillic Acid (HVA), Random, Urine
Calcitonin (Thyrocalcitonin)
Beta-amyloid (Aβ1-40 and Aβ1-42), Plasma
Triazolam, Urine
Hemosiderin Stain, Urine
Brugada Syndrome Multi-Gene Panel, NGS
SelectMDx for Prostate Cancer
Histoplasma capsulatum Antibody, CSF
LDS
Sign up
Log in
LDS
/
Medical Tests
/
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
Medical Test
Clinical Utility
Access to
BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
is restricted.
Sign up now
Loading...